| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2934150 | International Journal of Cardiology | 2008 | 9 Pages |
Abstract
Compared to abciximab + BMS, tirofiban infusion + SES implantation in STEMI patients was an economically dominant strategy, with an improved composite outcome and lower overall costs.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Marco Valgimigli, Nicole Mittmann, David J. Cohen, Gianluca Campo, Pierre K. Isogai, Soo Jin Seung, Brian Dulisse, Chiara Arcozzi, Paolo Squasi, Gianfranco Percoco, Roberto Ferrari,